As the designed conjugate is particular to MUC16 expressed in pancreatic cancer, it restricts its distribution and/or prolonged exposure to other tissues, thereby mitigating any off-target toxicity and false-positive images of normal tissue proximal to the pancreas. This evidence concerns the gene MUC16 and pancreatic neoplasm.